Drug eruptions are associated with increased length of stay in hospitalized patients with sepsis.

This study was conducted with the hypothesis that sepsis patients who suffer from DEs would have longer lengths of stay than sepsis patients without a DE during hospitalization. Keywords: drug eruption; sepsis; medical dermatology; hospitalization outcomes EN drug eruption sepsis medical dermatology hospitalization outcomes e319 e320 2 04/20/23 20230501 NES 230501 Sepsis patients have high mortality rates and frequently suffer persistent long-term health outcomes.[[1]] Sepsis patients are often placed on broad-spectrum antibiotics, the most frequent cause of cutaneous drug eruptions (DEs).[[3]] However, there is little research on DE impact on hospitalization length of stay or mortality in sepsis. [Extracted from the article]